Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.

Saved in:
Bibliographic Details
Title: Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.
Authors: Nag A; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Kt B; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Kumar J; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Ghosh S; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Podder D; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Chattopadhyay D; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Saha S; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Javed R; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Chatterji S; Department of Infectious Diseases, Tata Medical Center, Kolkata, IND., Rath A; Department of Lab Hematology, Tata Medical Center, Kolkata, IND., Nair R; Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, IND., Bharat S; Department of Medical Affair, Zydus Lifesciences Ltd, Ahmedabad, IND.
Source: Cureus [Cureus] 2025 Apr 26; Vol. 17 (4), pp. e83035. Date of Electronic Publication: 2025 Apr 26 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.83035